生物醫學資訊研究所

Keyphrases

1. Adjusted Hazard Ratio 6%
2. Age Groups 5%
3. Air Quality Index 6%
4. Area under the Receiver Operating Characteristic Curve 5%
5. Artificial Intelligence 6%
6. Artificial Neural Network 7%
7. Atopic Dermatitis 9%
8. Biological Characteristics 6%
9. Bullous Pemphigoid 14%
10. Cancer Cells 9%
11. Cancer Risk 10%
12. China 9%
13. Chronic Disease 5%
14. Chronic Hepatitis B 8%
15. Chronic Kidney Disease 9%
16. Cirrhosis 6%
17. Cloud Computing 6%
18. Comorbidity 11%
19. Comparative Analysis 8%
20. Confidence Interval 43%
21. COVID-19 13%
22. COVID-19 Cases 8%
23. COVID-19 Pandemic 7%
24. CUD A 14%
25. Cumulative Incidence 9%
26. Decision Support System 6%
27. Deep Learning 18%
28. Deep Learning Methods 10%
29. Deep Learning Model 6%
30. Dermatomyositis 7%
31. Disease-modifying Antirheumatic Drugs (DMARDs) 5%
32. Early Hepatocellular Carcinoma 7%
33. End-user Computing 7%
34. Excel VBA 8%
35. Gastric Cancer 19%
36. Genotype 7%
37. GPGPU 7%
38. GPU-based 5%
39. Graphics Processing Unit 12%
40. Gut Microbiota 7%
41. Hazard Ratio 18%
42. Healthcare Professionals 12%
43. Helicobacter Pylori (H. pylori) 15%
44. Helicobacter Pylori Eradication 7%
45. Helicobacter Pylori Infection 16%
46. Hepatitis C Virus 6%
47. Hepatocellular Carcinoma 20%
48. Hepatocellular Carcinoma Recurrence 6%
49. High Risk 7%
50. Imiquimod 11%
51. Imiquimod-induced 10%
52. In Cancer 10%
53. Indonesia 6%
54. Informatics 6%
55. Liver Resection 6%
56. Low Risk 6%
57. Machine Learning Algorithms 13%
58. Magnetic Resonance Imaging 6%
59. Malignancy 7%
60. Medical Center 10%
61. Meta-analysis 6%
62. Minimum Data Set 7%
63. Multivariate Analysis 6%
64. National Cohort Study 55%
65. National Health Insurance 7%
66. National Health Insurance Research Database (NHIRD) 6%
67. Network Applications 6%
68. Non-steroidal Anti-inflammatory Drugs (NSAIDs) 6%
69. Nucleos(t)ide Analogues 7%
70. Nursing 13%
71. Nursing Informatics 14%
72. Nursing Information System 6%
73. Odds Ratio 15%
74. Performance Prediction 10%
75. Polymyositis 7%
76. Population-based Cohort Study 21%
77. Prediction Accuracy 6%
78. Prediction Method 8%
79. Prediction Model 11%
80. Protein Subcellular Localization Prediction 7%
81. Proton Pump Inhibitors 6%
82. Psoriasis 13%
83. Radiofrequency Ablation 10%
84. Random Forest 5%
85. Randomized Controlled Trial 8%
86. Risk Factors 9%
87. Risk Reduction 12%
88. Rosaceae 7%
89. Schizophrenia 8%
90. Standardized Incidence Ratio 8%
91. Support System 18%
92. Systematic Meta-analysis 7%
93. Systems-based 6%
94. Taipei 7%
95. Taiwan 100%
96. Taiwan National Health Insurance Research Database 6%
97. Taiwanese 6%
98. Type 1 Diabetes Mellitus (T1DM) 6%
99. U-Net 8%
100. Vaccination 6%

Medicine and Dentistry

1. Abdominal Cancer 12%
2. Alanine Aminotransferase 5%
3. Antiviral Therapy 6%
4. Atopic Dermatitis 9%
5. Breast Cancer 9%
6. Bullous Pemphigoid 10%
7. Cancer 14%
8. Cancer Risk 9%
9. Case-Control Study 9%
10. Chronic Disease 5%
11. Chronic Hepatitis B 10%
12. Chronic Kidney Disease 8%
13. Cohort Analysis 55%
14. Comorbidity 11%
15. COVID-19 10%
16. Cumulative Incidence 6%
17. Dermatomyositis 7%
18. Diabetes 5%
19. Diabetes Mellitus 5%
20. Diseases 11%
21. Dupilumab 5%
22. Gut 6%
23. Gut Microbiota 7%
24. Hazard Ratio 18%
25. Helicobacter Pylori 18%
26. Hepatectomy 9%
27. Hepatitis B 7%
28. Hepatitis B Antigen 5%
29. Hepatitis B Virus 6%
30. Hepatocellular Carcinoma 21%
31. Infection 10%
32. Liver Cirrhosis 9%
33. Logistic Regression Analysis 5%
34. Long-Term Care 6%
35. Malignant Neoplasm 15%
36. Meta-Analysis 5%
37. Neoplasm 9%
38. Nonsteroid Antiinflammatory Agent 6%
39. Odds Ratio 11%
40. Placebo 5%
41. Polymyositis 7%
42. Prevalence 5%
43. Psoriasis 11%
44. Radiofrequency Ablation 9%
45. Recurrent Disease 7%
46. Rhinophyma 7%
47. Skin Cancer 5%
48. Standardized Incidence Ratio 6%
49. Stomach Acid 5%
50. Systematic Review 6%
51. Tenofovir Disoproxil 5%
52. Triage 5%